Abstract: A system and method for analyzing data from a plurality of computer environments. The computer environments are authenticated and data is imported to a memory location. The data is converted into a uniform format to enable expedited searching by one or more authenticated users. The data may be marked so that a user may determine which computer environment provided the data. The system may also create one or more indexes of the data to assist one or more users in searching the data.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: A system and method to detect and contain threatening executable code by employing a threat monitor, verifier, endpoint agent, and a security information and event management module. The system and method determine whether a threat has persisted or executed, and allow that information to be communicated back to the detection mechanism (or other system) such that a user (or machine) may make a decision to take further action such as to contain the threat quickly and/or permit the system to do so automatically.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulations, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: A system and method to communicate secure information between computing machines using an untrusted intermediate with resilience to disconnected network topology. The system and method utilize agnostic endpoints that are generalized to be interoperable among various systems, with their functionality based on their location in a network. The system and method enable horizontal scaling on the network. One or more clusters may be set up in a location within a network or series of networks in electronic communication, e.g., in a cloud or a sub-network, residing between a secure area of the network(s) and an unsecure area such as of an external network or portion of a network. The horizontal scaling allows the system to take advantage of a capacity of a local network. As long as an agent has connectivity to at least one locale of the network, the agent is advantageously operable to move data across the system.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: The present disclosure includes a method of maintaining rating groups and receiving, from a first user, a selection of a first rating group, from among the rating groups, to be applied to a set of users associated with the first user. Next, method includes receiving, from a user, a request for a piece of content from the content and determining that the user from which the request was received belongs to the set of users associated with the first user. The method also includes accessing information associated with the first rating group and determining whether the first rating group includes a rating for the requested piece of content. The method also includes determining whether or not to provide information to the requesting user conditioned on the indication or absence of a rating for the requested piece of content within the first rating group.

Abstract: The aspects disclosed herein are directed to systems, methods, implementations, and devices for evaluating the efficacy of optical fire placement(s) with a plume-based model. Employing the aspects disclosed herein, an implementer may review a real-world implementation and determine if said real-world implementation is covered adequately by a proposed optical fire placement strategy.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: According to a general aspect, a method includes receiving, at a network interface device at a user location, a request from a first machine located at the user location, the request including a first-machine identifier and a request to access through the network interface device a first location on a network. The method also includes logging, at the network interface device, the request from the first machine into a first-machine log for requests from the first machine, the logging into the first-machine log being based on the first-machine identifier. The method also includes receiving at the network interface device a request from a second machine located at the user location, the request from the second machine including a second-machine identifier and a request to access through the network interface device a second location on the network, and the network interface device, the first machine, and the second machine being located at a user location.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: According to a general aspect, a method includes maintaining rating groups, each rating group providing a rating for content compiled based on information received from a user evaluating the content. The method also includes receiving, from a first user, a selection of a first rating group to be applied to a set of users associated with the first user. The method also includes receiving, from a user, a request for a piece of content. The method also includes determining that the user from which the request was received belongs to the set of users associated with the first user. The method also includes, based upon the determination that the user belonged to the set of users associated with the first user, accessing information associated with the first rating group and determining whether the first rating group includes a rating for the requested piece of content.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: According to a general aspect, a method includes receiving, at a network interface device at a user location, a request from a first machine located at the user location, the request including a first-machine identifier and a request to access through the network interface device a first location on a network. The method also includes logging, at the network interface device, the request from the first machine into a first-machine log for requests from the first machine, the logging into the first-machine log being based on the first-machine identifier. The method also includes receiving at the network interface device a request from a second machine located at the user location, the request from the second machine including a second-machine identifier and a request to access through the network interface device a second location on the network, and the network interface device, the first machine, and the second machine being located at a user location.

Abstract: A system and method to detect and contain threatening executable code by employing a threat monitor, verifier, endpoint agent, and a security information and event management module. The system and method are a departure from and an improvement over conventional systems in that, among other things, the system and method allow an investigator to determine whether a threat has persisted or executed, and allow that information to be communicated back to the detection mechanism (or other system) such that a user (or machine) may make a decision to take further action such as to contain the threat quickly and/or permit the system to do so automatically.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.

Abstract: According to a general aspect, a method includes maintaining rating groups, each rating group providing a rating for content compiled based on information received from a user evaluating the content. The method also includes receiving, from a first user, a selection of a first rating group, from among the rating groups, to be applied to a set of users associated with the first user. The method also includes receiving, from a user, a request for a piece of content from the content. The method also includes determining that the user from which the request was received belongs to the set of users associated with the first user. The method also includes, based upon the determination that the user belonged to the set of users associated with the first user, accessing information associated with the first rating group and determining whether the first rating group includes a rating for the requested piece of content.

Abstract: According to a general aspect, a method includes maintaining rating groups, each rating group providing a rating for content compiled based on information received from a user evaluating the content. The method also includes receiving, from a first user, a selection of a first rating group, from among the rating groups, to be applied to a set of users associated with the first user. The method also includes receiving, from a user, a request for a piece of content from the content. The method also includes determining that the user from which the request was received belongs to the set of users associated with the first user. The method also includes, based upon the determination that the user belonged to the set of users associated with the first user, accessing information associated with the first rating group and determining whether the first rating group includes a rating for the requested piece of content.

Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.